Synopsis:
Common Insurance coverage has delivered a robust monetary efficiency in Q1 FY26 (June 2025), showcasing sturdy progress throughout all main parameters. The corporate has outperformed each on a YoY and QoQ foundation, underlining its operational effectivity and profitability momentum.
The corporate reported a wholesome 13% YoY progress in gross sales, whereas EBIDT and web revenue surged by 77% and 81%, respectively. EPS additionally confirmed a major 81% soar YoY. Though there was a marginal decline in EBIDT QoQ, the corporate maintained constant profitability, indicating sturdy fundamentals and secure enterprise operations.
With a market capitalization of Rs. 68,922 cr, the shares of Common Insurance coverage Company of India is at the moment buying and selling at Rs. 393.85 apiece, growing 5% from its earlier shut of Rs. 377.95, making a excessive of Rs. 400 apiece.
Q1FY26 Outcomes
In Q1 FY26, Common Insurance coverage reported a sturdy monetary efficiency with a 13% YoY improve in gross sales to Rs. 14,623 crore. EBIDT surged by 77% YoY to Rs. 2,605 crore, and web revenue rose sharply by 81% to Rs. 2,531 crore, reflecting sturdy operational effectivity.
On a QoQ foundation, gross sales grew by 10.7% from Rs. 13,209 crore, and web revenue remained secure in comparison with Rs. 2,499 crore in March 2025. Nonetheless, EBIDT noticed a slight dip of 13% QoQ from Rs. 2,998 crore. The corporate maintained regular profitability, supported by good income progress.
Concerning the firm
Common Insurance coverage Company of India (GIC Re) is the only real reinsurance firm owned by the Authorities of India. It primarily gives reinsurance help to direct insurance coverage firms in India and overseas. This implies GIC Re doesn’t straight promote insurance coverage to prospects however slightly insures the insurers, serving to them handle threat by taking over a portion of their liabilities.
GIC Re affords reinsurance options throughout varied segments, together with hearth, marine, motor, well being, agriculture, aviation, engineering, and legal responsibility insurance coverage. Moreover, International Institutional Buyers (FIIs) have proven elevated confidence within the firm, with their stake rising from 1.93% to 2.12%.
The corporate has demonstrated sturdy monetary efficiency, with a ROCE of 15.6% and ROE of 12.7%. The corporate has delivered a powerful revenue progress of 111% CAGR during the last 5 years, reflecting sturdy operational effectivity and profitability. Additionally maintained a wholesome dividend payout ratio of twenty-two.7%, indicating constant returns to shareholders.
Written by Manideep Appana
Disclaimer
The views and funding suggestions expressed by funding consultants/broking homes/score companies on tradebrains.in are their very own, and never that of the web site or its administration. Investing in equities poses a threat of economic losses. Buyers should subsequently train due warning whereas investing or buying and selling in shares. Commerce Brains Applied sciences Personal Restricted or the creator will not be accountable for any losses triggered because of the choice primarily based on this text. Please seek the advice of your funding advisor earlier than investing.
